메뉴 건너뛰기




Volumn 5, Issue , 2011, Pages 84-105

Improving Animal Welfare and Reducing Animal Use for Veterinary Vaccine Potency Testing: State-Of-The-Science and Future Directions

Author keywords

ICCVAM; Reduction alternatives; Refinement alternatives; Vaccine potency testing; Vaccine safety testing; Veterinary vaccines

Indexed keywords

BACTERIAL VACCINE; CLOSTRIDIUM VACCINE; FISH VACCINE; INACTIVATED SWINE ERYSIPELAS VACCINE; LEPTOSPIROSIS VACCINE; PERTUSSIS VACCINE; POULTRY VACCINE; RABIES VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; VACCINE; VETERINARY VACCINE;

EID: 84555196698     PISSN: None     EISSN: 1877282X     Source Type: Journal    
DOI: 10.1016/j.provac.2011.10.006     Document Type: Article
Times cited : (18)

References (119)
  • 1
    • 84855981850 scopus 로고    scopus 로고
    • Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). The NICEATM-ICCVAM five-year plan (2008-2012): a plan to advance alternative test methods of high scientific quality to protect and advance the health of people, animals, and the environment. National Institute of Environmental Health Sciences NIH Publication No. 08-6410
    • Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). The NICEATM-ICCVAM five-year plan (2008-2012): a plan to advance alternative test methods of high scientific quality to protect and advance the health of people, animals, and the environment. National Institute of Environmental Health Sciences, 2008. NIH Publication No. 08-6410. http://iccvam.niehs.nih.gov/docs/5yearplan.htm.
    • (2008)
  • 2
    • 84555172398 scopus 로고    scopus 로고
    • Introduction and summary of the international workshop on alternative methods to reduce, refine, and replace the use of animals in vaccine potency and safety testing: state of the science and future directions. Proc Vaccinol (current issue)
    • Stokes WS, Kulpa-Eddy J, McFarland RM. Introduction and summary of the international workshop on alternative methods to reduce, refine, and replace the use of animals in vaccine potency and safety testing: state of the science and future directions. Proc Vaccinol 2011 (current issue).
    • (2011)
    • Stokes, W.S.1    Kulpa-Eddy, J.2    McFarland, R.M.3
  • 9
    • 84555191831 scopus 로고    scopus 로고
    • Veterinary vaccines and their importance to animal health and public health.
    • Roth J. Veterinary vaccines and their importance to animal health and public health. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Roth, J.1
  • 10
    • 84555190332 scopus 로고    scopus 로고
    • Human vaccines and their importance to public health.
    • Schuchat A. Human vaccines and their importance to public health. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Schuchat, A.1
  • 11
    • 84555190330 scopus 로고    scopus 로고
    • FDA Requirements for human vaccine safety and potency testing.
    • Finn T. U.S. FDA Requirements for human vaccine safety and potency testing. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Finn, T.U.S.1
  • 12
    • 84555193290 scopus 로고    scopus 로고
    • USDA requirements for veterinary vaccine safety and potency testing.
    • Hill RE. USDA requirements for veterinary vaccine safety and potency testing. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Hill, R.E.1
  • 14
    • 84555217945 scopus 로고    scopus 로고
    • European regulatory requirements for veterinary vaccine safety and potency testing and recent progress toward reducing animal use.
    • Woodland R. European regulatory requirements for veterinary vaccine safety and potency testing and recent progress toward reducing animal use. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Woodland, R.1
  • 16
    • 84555196680 scopus 로고    scopus 로고
    • International Regulatory Requirements for Vaccine Safety and Potency Testing: A WHO perspective.
    • Shin J, Lei D, Conrad C, Knezevic I, Wood D. International Regulatory Requirements for Vaccine Safety and Potency Testing: A WHO perspective. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Shin, J.1    Lei, D.2    Conrad, C.3    Knezevic, I.4    Wood, D.5
  • 17
    • 84555190324 scopus 로고    scopus 로고
    • Overview of currently approved veterinary vaccine potency testing methods and methods in development that do not require animal use.
    • Draayer H. Overview of currently approved veterinary vaccine potency testing methods and methods in development that do not require animal use. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Draayer, H.1
  • 18
    • 84555217940 scopus 로고    scopus 로고
    • Case study of development, validation, and acceptance of a non-animal method for assessing veterinary vaccine potency.
    • Claassen I. Case study of development, validation, and acceptance of a non-animal method for assessing veterinary vaccine potency. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Claassen, I.1
  • 19
    • 84855981859 scopus 로고    scopus 로고
    • Overview of the current status of human vaccine potency testing methods that replace animals. Presented at: International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: State of the Science and Future Directions. NICEAM. Bethesda, MD. September Available at:
    • Levis R. Overview of the current status of human vaccine potency testing methods that replace animals. Presented at: International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: State of the Science and Future Directions. NICEAM. Bethesda, MD. September 2010. Available at: http://iccvam.niehs.nih.gov/meetings/BiologicsWksp-2010/BiologicsWksp-present.htm.
    • (2010)
    • Levis, R.1
  • 20
    • 84555190321 scopus 로고    scopus 로고
    • A Case study of development, validation, and acceptance of a non-animal method for assessing human vaccine potency.
    • Descamps J, et al. A Case study of development, validation, and acceptance of a non-animal method for assessing human vaccine potency. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Descamps, J.1
  • 21
    • 84555196668 scopus 로고    scopus 로고
    • Overview of currently approved serological methods with a focus on diphtheria and tetanus toxoid potency testing.
    • Keller JE. Overview of currently approved serological methods with a focus on diphtheria and tetanus toxoid potency testing. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Keller, J.E.1
  • 22
    • 84855915728 scopus 로고    scopus 로고
    • Refinement alternatives for veterinary vaccine potency testing: overview of currently approved serological methods. Presented at: International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: State of the Science and Future Directions. NICEAM. Bethesda, MD. September Available at:
    • Srinivas G. Refinement alternatives for veterinary vaccine potency testing: overview of currently approved serological methods. Presented at: International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: State of the Science and Future Directions. NICEAM. Bethesda, MD. September 2010. Available at: http://iccvam.niehs.nih.gov/meetings/BiologicsWksp-2010/BiologicsWksp-present.htm.
    • (2010)
    • Srinivas, G.1
  • 24
    • 84555217934 scopus 로고    scopus 로고
    • Development and validation of serological methods for human vaccine potency testing: case study of an anthrax vaccine.
    • Arciniega JL, Domínguez-Castillo RI. Development and validation of serological methods for human vaccine potency testing: case study of an anthrax vaccine. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol (current issue)
    • Arciniega, J.L.1    Domínguez-Castillo, R.I.2
  • 26
    • 84555191809 scopus 로고    scopus 로고
    • Examples of approaches to reducing animal numbers in vaccine potency testing
    • (current issue)
    • Kulpa-Eddy J, Srinivas G. Examples of approaches to reducing animal numbers in vaccine potency testing. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol.
    • Kulpa-Eddy, J.1    Srinivas, G.2
  • 27
    • 84555190317 scopus 로고    scopus 로고
    • Application of the consistency approach in the United States to reduce animal use in vaccine potency testing
    • (current issue)
    • Kulpa-Eddy J, Dusek D. Application of the consistency approach in the United States to reduce animal use in vaccine potency testing. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol.
    • Kulpa-Eddy, J.1    Dusek, D.2
  • 28
    • 84555217925 scopus 로고    scopus 로고
    • Veterinary vaccine post-licensing safety testing: overview of current regulatory requirements and accepted alternatives
    • (current issue)
    • Gifford G, Agrawal P, Hutchings D, Yarosh O. Veterinary vaccine post-licensing safety testing: overview of current regulatory requirements and accepted alternatives. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol.
    • Gifford, G.1    Agrawal, P.2    Hutchings, D.3    Yarosh, O.4
  • 30
    • 84555191800 scopus 로고    scopus 로고
    • Toward replacement of the monkey neurovirulence test in vaccine safety testing
    • (current issue)
    • Rubin SA. Toward replacement of the monkey neurovirulence test in vaccine safety testing. Proc Vaccinol 2011 (current issue).
    • (2011) Proc Vaccinol.
    • Rubin, S.A.1
  • 31
    • 84855940069 scopus 로고    scopus 로고
    • United States Public Law 430 of 1913 and Public Law 99-198 (1985 amendments to the Virus-Serum-Toxin Act); Title 21 U.S. Code, Chapter 5 §§ 151 et. seq
    • United States Public Law 430 of 1913 and Public Law 99-198 (1985 amendments to the Virus-Serum-Toxin Act); Title 21 U.S. Code, Chapter 5 §§ 151 et. seq.
  • 32
    • 84855915726 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics Notice 04-09: Use of Humane Endpoints in Animal Testing of Biological Products. Available at:
    • United States Department of Agriculture, Center for Veterinary Biologics Notice 04-09: Use of Humane Endpoints in Animal Testing of Biological Products. 2004. Available at: http://www.aphis.usda.gov/animal_health/vet_biologics/vb_notices_2004.shtml.
    • (2004)
  • 33
    • 13844279157 scopus 로고    scopus 로고
    • The European Pharmacopoeia and humane endpoints
    • In: Hendriksen CFM, Morton DB, editors. Humane Endpoints in Animal Experiments for Biomedical Research. London, Royal Society of Medicine Press
    • Castle P. The European Pharmacopoeia and humane endpoints. In: Hendriksen CFM, Morton DB, editors. Humane Endpoints in Animal Experiments for Biomedical Research. London, Royal Society of Medicine Press, 1999:15-19.
    • (1999) , pp. 15-19
    • Castle, P.1
  • 34
    • 0003060484 scopus 로고    scopus 로고
    • Reducing unrelieved pain and distress in laboratory animals using humane endpoints
    • Stokes, WS. Reducing unrelieved pain and distress in laboratory animals using humane endpoints. ILAR Journal 2000;41(2):59-61.
    • (2000) ILAR Journal , vol.41 , Issue.2 , pp. 59-61
    • Stokes, W.S.1
  • 35
    • 0036053309 scopus 로고    scopus 로고
    • Humane endpoints for laboratory animals used in regulatory testing
    • Stokes, WS. Humane endpoints for laboratory animals used in regulatory testing. ILAR Journal 2002; 43(Suppl):S31-S38.
    • (2002) ILAR Journal. , vol.43 , Issue.SUPPL.
    • Stokes, W.S.1
  • 36
    • 84555172396 scopus 로고    scopus 로고
    • OLAW/ARENA (Office of Laboratory Animal Welfare/Applied Research Ethics National Association). Institutional Animal Care and Use Committee Guidebook. 2nd ed. Bethesda: National Institutes of Health;
    • OLAW/ARENA (Office of Laboratory Animal Welfare/Applied Research Ethics National Association). Institutional Animal Care and Use Committee Guidebook. 2nd ed. Bethesda: National Institutes of Health; 2002.
    • (2002)
  • 37
    • 79251482684 scopus 로고    scopus 로고
    • United States Animal Welfare Act. Transportation, sale, and handling of certain animals
    • Title 7. U.S. Code, Chapter 54 §
    • United States Animal Welfare Act. Transportation, sale, and handling of certain animals. Title 7. U.S. Code, Chapter 54 § 2131-2159.
  • 38
    • 0001748577 scopus 로고    scopus 로고
    • European Union - Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes
    • 18/12/1986. Available at: in, press.
    • European Union - Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal L 358, 1-28; 18/12/1986. Available at: http://eur-x.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX: 31986L0609:EN: HTM.L., in, press.,.
    • Official Journal , Issue.L 358 , pp. 1-28
  • 39
    • 79957595848 scopus 로고    scopus 로고
    • Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes
    • Available at:
    • Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European Union Official Journal of the European Union, L276; 33-79. Available at:http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L: 2010:276:0033:0079:EN:PDF.
    • Official Journal of the European Union Official Journal of the European Union , Issue.L276 , pp. 33-79
  • 40
    • 84855925411 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 117- Standard Requirements. Section 117.4e. Test Animals.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 117- Standard Requirements. Section 117.4e. Test Animals. http://law.justia.com/us/cfr/title09/9-1.0.1.5.54.html#9:1.0.1.5.54.0.77.4.
  • 41
    • 84555173500 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 01/2008:0062. Vaccines for Veterinary Use, Ph.Eur. 7th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe
    • European Pharmacopoeia. Monograph 01/2008:0062. Vaccines for Veterinary Use, Ph.Eur. 7th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2010.
    • (2010)
  • 42
    • 0034573475 scopus 로고    scopus 로고
    • Refinement of vaccine potency testing with the use of humane endpoints
    • Hendriksen C, Steen B. Refinement of vaccine potency testing with the use of humane endpoints. ILAR Journal 2000;41(2):105-113.
    • (2000) ILAR Journal , vol.41 , Issue.2 , pp. 105-113
    • Hendriksen, C.1    Steen, B.2
  • 43
    • 84555198241 scopus 로고    scopus 로고
    • Center for Veterinary Biologics Notice No. 04-09: Use of Humane Endpoints in Animal Testing of Biological Products
    • Title 9 Code of Federal Regulations (9CFR)(e)
    • Center for Veterinary Biologics Notice No. 04-09: Use of Humane Endpoints in Animal Testing of Biological Products. 2004. Title 9 Code of Federal Regulations (9CFR) Part 116.4(e).
    • (2004) , vol.4 , Issue.PART 116
  • 44
    • 84855915723 scopus 로고    scopus 로고
    • Canadian Council on Animal Care (CCAC). CCAC guidelines on: choosing an appropriate endpoint in experiments using animals for research, teaching and testing. Ottawa, Canada
    • Canadian Council on Animal Care (CCAC). CCAC guidelines on: choosing an appropriate endpoint in experiments using animals for research, teaching and testing. Ottawa, Canada, 1998 (http://ccac.ca/en_/standards/guidelines).
    • (1998)
  • 46
    • 63849201560 scopus 로고    scopus 로고
    • Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement
    • Hendriksen C. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement. Expert Rev Vaccines 2008;8(3):313-322.
    • (2008) Expert Rev Vaccines. , vol.8 , Issue.3 , pp. 313-322
    • Hendriksen, C.1
  • 47
    • 84855942490 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113- Standard Requirements. Section 113.209. SAM 308: Supplemental Assay Method for Potency Testing of Inactivated Rabies Vaccines in Mice Using the National Institutes of Health Test.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.209. SAM 308: Supplemental Assay Method for Potency Testing of Inactivated Rabies Vaccines in Mice Using the National Institutes of Health Test. 2007. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_300_series.shtml.
    • (2007)
  • 48
    • 84555172395 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 01/2010:0451. Rabies Vaccine (Inactivated) for Veterinary Use. 7th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe
    • European Pharmacopoeia. Monograph 01/2010:0451. Rabies Vaccine (Inactivated) for Veterinary Use. 7th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2010.
    • (2010)
  • 49
    • 0008466677 scopus 로고    scopus 로고
    • Humane endpoints for the estimation of lethality rates in the potency testing of rabies vaccines
    • Cussler K, DB Morton, C Hendriksen. Humane endpoints for the estimation of lethality rates in the potency testing of rabies vaccines. Alternativen zu Tierexperimenten 1998;15 Suppl:40-42.
    • (1998) Alternativen zu Tierexperimenten , vol.15 , Issue.SUPPL. , pp. 40-42
    • Cussler, K.1    Morton, D.B.2    Hendriksen, C.3
  • 50
    • 84555198245 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 04/2008:0216. Rabies Vaccine for Human Use Prepared in Cell Culture. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe
    • European Pharmacopoeia. Monograph 04/2008:0216. Rabies Vaccine for Human Use Prepared in Cell Culture. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2008.
    • (2008)
  • 51
    • 84855925411 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113 - Standard Requirements, Section 113.6. Animal and Plant Health Inspection Service Testing.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products, Part 113 - Standard Requirements, Section 113.6. Animal and Plant Health Inspection Service Testing. http://www.access.gpo.gov/nara/cfr/waisidx_09/9cfr113_09.html.
  • 53
    • 84855925411 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113 - Standard Requirements, Section 113.3. Sampling of Biological Products.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products, Part 113 - Standard Requirements, Section 113.3. Sampling of Biological Products. http://www.access.gpo.gov/nara/cfr/waisidx_09/9cfr113_09.html.
  • 55
    • 33846336748 scopus 로고    scopus 로고
    • The rabies peripheral challenge test: more accurate determination of vaccine potency
    • Wunderli PS, Dreesen DW, Miller TJ, Baer GM. The rabies peripheral challenge test: more accurate determination of vaccine potency. Vaccine 2006;24:7115-7123.
    • (2006) Vaccine. , vol.24 , pp. 7115-7123
    • Wunderli, P.S.1    Dreesen, D.W.2    Miller, T.J.3    Baer, G.M.4
  • 56
    • 84855940067 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products, Part 113 - Standard Requirements, Section 113.67. Erysipelothrix Rhusiopathiae Vaccine.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products, Part 113 - Standard Requirements, Section 113.67. Erysipelothrix Rhusiopathiae Vaccine. http://www.access.gpo.gov/nara/cfr/waisidx_09/9cfr113_09.html.
  • 57
    • 84855925411 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113 - Standard Requirements, Section 113.326. Avian Pox Vaccineccine.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products, Part 113 - Standard Requirements, Section 113.326. Avian Pox Vaccineccine. http://www.access.gpo.gov/nara/cfr/waisidx_09/9cfr113_09.html.
  • 58
    • 84555173480 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113- Standard Requirements. Section 113.106. SAM 200: Supplemental Assay Method for Potency Testing Products Containing Clostridium chauvoei Antigen.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.106. SAM 200: Supplemental Assay Method for Potency Testing Products Containing Clostridium chauvoei Antigen. 2008. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_200_series.shtml.
    • (2008)
  • 59
    • 84555173480 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113- Standard Requirements. Section 113.107. SAM 209: Supplemental Assay Method for Potency Testing Products Containing Clostridium haemolyticum Antigen.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.107. SAM 209: Supplemental Assay Method for Potency Testing Products Containing Clostridium haemolyticum Antigen. 2008. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_200_series.shtml.
    • (2008)
  • 60
    • 84555198231 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113- Standard Requirements. Section 113.110. SAM 213: Supplemental Assay Method for Potency Testing of Clostridium botulinum Type C Bacterin-Toxoids.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.110. SAM 213: Supplemental Assay Method for Potency Testing of Clostridium botulinum Type C Bacterin-Toxoids. 2009.
    • (2009)
  • 61
    • 84555173480 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113- Standard Requirements. Section 113.111. SAM 201: Supplemental Assay Method for Potency Testing of Clostridium perfringens Type C Beta Antigen.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.111. SAM 201: Supplemental Assay Method for Potency Testing of Clostridium perfringens Type C Beta Antigen. 2008. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_200_series.shtml.
    • (2008)
  • 62
    • 84855942490 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113- Standard Requirements. Section 113.112. SAM 203: Supplemental Assay Method for Potency Testing of Clostridium perfringens Type D Epsilon Antigen.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.112. SAM 203: Supplemental Assay Method for Potency Testing of Clostridium perfringens Type D Epsilon Antigen. 2007. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_200_series.shtml.
    • (2007)
  • 63
    • 84855940068 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.108. SAM 207: Supplemental Assay Method for Potency Testing Clostridium novyi Type B Alpha Antigen.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.108. SAM 207: Supplemental Assay Method for Potency Testing Clostridium novyi Type B Alpha Antigen. 2007. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_200_series.shtml.
    • (2007)
  • 64
    • 84555172383 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113- Standard Requirements. Section 113.109. SAM 212: Supplemental Assay Method for Potency Testing of Clostridium sordellii Antigen
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.109. SAM 212: Supplemental Assay Method for Potency Testing of Clostridium sordellii Antigen. 2010.
    • (2010)
  • 65
    • 84555193223 scopus 로고    scopus 로고
    • Alternatives to animal challenge tests in the batch control of Leptospira vaccines for veterinary use. Pharmeuropa Special Issue
    • (eds).Strasbourg: Council of Europe, EDQM; Bio
    • Castle P, Coune C, Ellis W, Esposito-Farese M-E, Spieser J-M, LeTarnec C, (eds). Alternatives to animal challenge tests in the batch control of Leptospira vaccines for veterinary use. Pharmeuropa Special Issue. Strasbourg: Council of Europe, EDQM; 1999;Bio 99-102.
    • (1999) , pp. 99-102
    • Castle, P.1    Coune, C.2    Ellis, W.3    Esposito-Farese, M.-E.4    Spieser, J.-M.5    LeTarnec, C.6
  • 66
    • 84884138067 scopus 로고    scopus 로고
    • Guinea pig serology as an alternative to the hamster challenge test for potency testing of Leptospira hardjo vaccines. Pharmeuropa
    • Ebert E. Guinea pig serology as an alternative to the hamster challenge test for potency testing of Leptospira hardjo vaccines. Pharmeuropa 1999;102-110.
    • (1999) , pp. 102-110
    • Ebert, E.1
  • 67
    • 84555173480 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products
    • Part 113- Standard Requirements. Section 113.101. SAM 608: Supplemental Assay Method for Potency assay of Leptospira interrogans Serovar pomona Bacterins.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.101. SAM 608: Supplemental Assay Method for Potency assay of Leptospira interrogans Serovar pomona Bacterins. 2008.
    • (2008)
  • 68
    • 84555173496 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.103. SAM 609: Supplemental Assay Method for Potency assay of Leptospira interrogans Serovar canicola Bacterins.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.103. SAM 609: Supplemental Assay Method for Potency assay of Leptospira interrogans Serovar canicola Bacterins. 2008.
    • (2008)
  • 69
    • 84555172391 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.102. SAM 610: Supplemental Assay Method for Potency assay of Leptospira interrogans Serovar icterohaemorrhagiae Bacterins
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.102. SAM 610: Supplemental Assay Method for Potency assay of Leptospira interrogans Serovar icterohaemorrhagiae Bacterins. 2008.
    • (2008)
  • 70
    • 84555173486 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.104. SAM 617: Supplemental Assay Method for Potency assay of Leptospira interrogans Serovar grippotyphosa Bacterins
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.104. SAM 617: Supplemental Assay Method for Potency assay of Leptospira interrogans Serovar grippotyphosa Bacterins. 2008.
    • (2008)
  • 71
    • 84555198218 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 01/2008:0064. Swine Erysipelas Vaccine (Inactivated). 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe
    • European Pharmacopoeia. Monograph 01/2008:0064. Swine Erysipelas Vaccine (Inactivated). 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2008.
    • (2008)
  • 72
    • 84855968477 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, SAM 217: Supplemental Assay Method for Potency Testing Tetanus Toxoid by ELISA.
    • United States Department of Agriculture, Center for Veterinary Biologics, SAM 217: Supplemental Assay Method for Potency Testing Tetanus Toxoid by ELISA. 2009. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_200_series.shtml.
    • (2009)
  • 73
    • 84555198219 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 01/2008:0697. Tetanus Vaccine for Veterinary Use. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe
    • European Pharmacopoeia. Monograph 01/2008:0697. Tetanus Vaccine for Veterinary Use. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2008.
    • (2008)
  • 74
    • 84555193247 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 01/2008:0363. Clostridium perfringens vaccine for veterinary use. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe
    • European Pharmacopoeia. Monograph 01/2008:0363. Clostridium perfringens vaccine for veterinary use. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2008.
    • (2008)
  • 75
    • 84555193248 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 01/2008:0364. Clostridium septicum vaccine for veterinary use. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe
    • European Pharmacopoeia. Monograph 01/2008:0364. Clostridium septicum vaccine for veterinary use. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2008.
    • (2008)
  • 76
    • 84555172384 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 01/2010:0362. Clostridium novyi (type B) vaccine for veterinary use. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe
    • European Pharmacopoeia. Monograph 01/2010:0362. Clostridium novyi (type B) vaccine for veterinary use. 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2010.
    • (2010)
  • 77
    • 64949104542 scopus 로고    scopus 로고
    • Three Rs achievements in vaccinology
    • AATEX Special Issue
    • Hendriksen C. Three Rs achievements in vaccinology. AATEX Special Issue 2007;14:575-579.
    • (2007) , vol.14 , pp. 575-579
    • Hendriksen, C.1
  • 78
    • 84555198239 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 01/2008:0447. Canine Leptospirosis vaccine (inactivated). 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe;
    • European Pharmacopoeia. Monograph 01/2008:0447. Canine Leptospirosis vaccine (inactivated). 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2008.
    • (2008)
  • 79
    • 84555173497 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph 01/2008:1939. Bovine leptospirosis vaccine (inactivated). 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe
    • European Pharmacopoeia. Monograph 01/2008:1939. Bovine leptospirosis vaccine (inactivated). 6th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2008.
    • (2008)
  • 80
    • 79952475204 scopus 로고    scopus 로고
    • Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use
    • Kramer B, Bruckner L, Daas A, Milne C. Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use. Pharmeuropa Bio 2010;37-55.
    • (2010) Pharmeuropa Bio. , pp. 37-55
    • Kramer, B.1    Bruckner, L.2    Daas, A.3    Milne, C.4
  • 81
    • 63249116538 scopus 로고    scopus 로고
    • The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines
    • Kramer B, Schildger H, Behrensdorf-Nicol HA, Hanschmann KM, Duchow K. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines. Biologicals 2009;37(2):119-126.
    • (2009) Biologicals. , vol.37 , Issue.2 , pp. 119-126
    • Kramer, B.1    Schildger, H.2    Behrensdorf-Nicol, H.A.3    Hanschmann, K.M.4    Duchow, K.5
  • 82
    • 0032029478 scopus 로고    scopus 로고
    • Development of a florescent antibody virus neutralization test (FAVN test) for the quantitation of rabies-neutralising antibody
    • Cliquet F, Aubert M, Sange L. Development of a florescent antibody virus neutralization test (FAVN test) for the quantitation of rabies-neutralising antibody. Journal of Immunological Methods 1998;212:79-87.
    • (1998) Journal of Immunological Methods. , vol.212 , pp. 79-87
    • Cliquet, F.1    Aubert, M.2    Sange, L.3
  • 84
    • 84855968473 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. SAM 315: Supplemental Assay Method for the Detection of Serum Neutralizing Antibodies to Rabies Virus Using the Rapid Fluorescent Focus Inhibition Test (RFFIT).
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. SAM 315: Supplemental Assay Method for the Detection of Serum Neutralizing Antibodies to Rabies Virus Using the Rapid Fluorescent Focus Inhibition Test (RFFIT). 2011. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_300_series.shtml.
    • (2011)
  • 85
    • 84555193250 scopus 로고    scopus 로고
    • European Pharmacopoeia. Monograph XXXX: 0451 - Rabies vaccine (inactivated) for veterinary use. Pharmeuropa
    • European Pharmacopoeia. Monograph XXXX: 0451 - Rabies vaccine (inactivated) for veterinary use. Pharmeuropa 2011;13:128-131.
    • (2011) , vol.13 , pp. 128-131
  • 86
    • 0035825058 scopus 로고    scopus 로고
    • Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test
    • Rosskopf-Streicher U, Johannes S, Wilhelm M, Cussler K. Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test. Vaccine 2001;19:1477-1483.
    • (2001) Vaccine. , vol.19 , pp. 1477-1483
    • Rosskopf-Streicher, U.1    Johannes, S.2    Wilhelm, M.3    Cussler, K.4
  • 87
    • 0001877807 scopus 로고
    • Wirksamkeitsprüfung von Rotlaufimpfstoffen an der Labormaus. ELISA kontra Infektionsversuch
    • Beckmann R, Cussler K. Wirksamkeitsprüfung von Rotlaufimpfstoffen an der Labormaus. ELISA kontra Infektionsversuch. ALTEX (Suppl) 1994;1:39-45.
    • (1994) ALTEX. , vol.1 , Issue.SUPPL. , pp. 39-45
    • Beckmann, R.1    Cussler, K.2
  • 88
    • 84855915722 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113. SAM 613: Supplemental Assay Method for In vitro Potency Testing of Erysipelothrix rhusiopathiae Bacterins
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113. SAM 613: Supplemental Assay Method for In vitro Potency Testing of Erysipelothrix rhusiopathiae Bacterins. 2009. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_600_series.shtml.
    • (2009)
  • 89
    • 84855968478 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.119. SAM 611: Supplemental Assay Method for Potency Testing of Erysipelas Bacterins in Mice.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.119. SAM 611: Supplemental Assay Method for Potency Testing of Erysipelas Bacterins in Mice. 2009. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_600_series.shtml.
    • (2009)
  • 91
    • 84555193277 scopus 로고    scopus 로고
    • EDQM. Alternative potency testing and other possible related quality issues for veterinary clostridial vaccines
    • Pharmeuropa, 1997 Special Issue, Bio 97-1. Strasbourg, France: European Department for the Quality of Medicines
    • EDQM. Alternative potency testing and other possible related quality issues for veterinary clostridial vaccines. Pharmeuropa, 1997 Special Issue, Bio 97-1. Strasbourg, France: European Department for the Quality of Medicines.
  • 92
    • 3242742954 scopus 로고    scopus 로고
    • Quality assurance of C. perfringens epsilon toxoid vaccines- ELISA versus mouse neutralisation test
    • Rosskopf-Streicher U, Volkers P, Noeske K, Werner, E. Quality assurance of C. perfringens epsilon toxoid vaccines- ELISA versus mouse neutralisation test. Alternativen zu Tierexperimenten 2004; 21(Suppl.):65-69.
    • (2004) Alternativen zu Tierexperimenten. , vol.21 , Issue.SUPPL. , pp. 65-69
    • Rosskopf-Streicher, U.1    Volkers, P.2    Noeske, K.3    Werner, E.4
  • 93
    • 0027992359 scopus 로고
    • Interlaboratory validation of the in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use
    • Hendriksen C, Woltjes J, Akkermans AM, van der Gun JW, Marsman FR, Verschure MH, Veldman K. Interlaboratory validation of the in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use. Biologicals 1994;22:257-268.
    • (1994) Biologicals. , vol.22 , pp. 257-268
    • Hendriksen, C.1    Woltjes, J.2    Akkermans, A.M.3    van der Gun, J.W.4    Marsman, F.R.5    Verschure, M.H.6    Veldman, K.7
  • 94
    • 84555193258 scopus 로고    scopus 로고
    • Council of Europe. 2.7.8 Assay of Tetanus vaccine (adsorbed). European Pharmacopoeia. Strasbourg, France: Council of Europe
    • Council of Europe. 2.7.8 Assay of Tetanus vaccine (adsorbed). European Pharmacopoeia. 1996. Strasbourg, France: Council of Europe.
    • (1996)
  • 95
    • 84855968479 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, SAM 206: Supplemental Assay Method for Potency Testing Tetanus Antitoxins.
    • United States Department of Agriculture, Center for Veterinary Biologics, SAM 206: Supplemental Assay Method for Potency Testing Tetanus Antitoxins. 2007. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_200_series.shtml.
    • (2007)
  • 96
    • 84855940065 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products, Part 113 - Standard Requirements, Section 113.105. Leptospira Hardjo Bacterin.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products, Part 113 - Standard Requirements, Section 113.105. Leptospira Hardjo Bacterin. http://www.access.gpo.gov/nara/cfr/waisidx_09/9cfr113_09.html.
  • 97
    • 84855915720 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Veterinary Services Memorandum No. 800.90. Guidelines for veterinary biological relative potency assays and reference preparations based on ELISA antigen quantification
    • United States Department of Agriculture, Center for Veterinary Biologics, Veterinary Services Memorandum No. 800.90. Guidelines for veterinary biological relative potency assays and reference preparations based on ELISA antigen quantification. 1998. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_vs_memos_2.shtml.
    • (1998)
  • 98
    • 84855933770 scopus 로고    scopus 로고
    • World Health Organization. Rabies vaccines: WHO Position paper. No 32
    • World Health Organization. Rabies vaccines: WHO Position paper. No 32, 2010, 85; 309-320. (http://www.who.int/wer).
    • (2010) , vol.85 , pp. 309-320
  • 99
    • 0001271311 scopus 로고    scopus 로고
    • A rapid tissue culture test for determining rabies neutralising antibody
    • In: Meslin F-X, Kaplan MM, Hoprowski H, editors. Laboratory Techniques in Rabies. Geneva, Switzerland, World Trade Organization
    • Smith JS, Yager PA, Baer GM. A rapid tissue culture test for determining rabies neutralising antibody. In: Meslin F-X, Kaplan MM, Hoprowski H, editors. Laboratory Techniques in Rabies. Geneva, Switzerland, World Trade Organization 1996;4:354-357.
    • (1996) , vol.4 , pp. 354-357
    • Smith, J.S.1    Yager, P.A.2    Baer, G.M.3
  • 100
    • 84855981854 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Veterinary Services Memorandum No. 800.104. In Vitro serial release potency test for completed product containing Clostridium chauvoei.
    • United States Department of Agriculture, Center for Veterinary Biologics, Veterinary Services Memorandum No. 800.104. In Vitro serial release potency test for completed product containing Clostridium chauvoei. 2003. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_vs_memos_3.shtml.
    • (2003)
  • 101
    • 84555193253 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.106. SAM 220: In Vitro Serial Release Potency Test for Completed Product Containing Clostridium chauvoei.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.106. SAM 220: In Vitro Serial Release Potency Test for Completed Product Containing Clostridium chauvoei. 2003.
    • (2003)
  • 102
    • 84855981855 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.101. SAM 624: Supplemental Assay Method for in vitro Potency testing of Leptospira interrogans Serovar pomona Bacterins.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.101. SAM 624: Supplemental Assay Method for in vitro Potency testing of Leptospira interrogans Serovar pomona Bacterins. 2009. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_600_series.shtml.
    • (2009)
  • 103
    • 84855940064 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.103. SAM 625: Supplemental Assay Method for in vitro Potency testing of Leptospira interrogans Serovar canicola Bacterins
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.103. SAM 625: Supplemental Assay Method for in vitro Potency testing of Leptospira interrogans Serovar canicola Bacterins. 2009. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_600_series.shtml.
    • (2009)
  • 104
    • 84855981853 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.104. SAM 626: Supplemental Assay Method for in vitro Potency testing of Leptospira interrogans Serovar grippotyphosa Bacterins
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.104. SAM 626: Supplemental Assay Method for in vitro Potency testing of Leptospira interrogans Serovar grippotyphosa Bacterins. 2009. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_600_series.shtml.
    • (2009)
  • 105
    • 84855915719 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.102. SAM 627: Supplemental Assay Method for in vitro Potency testing of Leptospira interrogans Serovar icterohaemorrhagiae Bacterins.
    • United States Department of Agriculture, Center for Veterinary Biologics, Code of Federal Regulations, Title 9, Animals and Animal Products. Part 113- Standard Requirements. Section 113.102. SAM 627: Supplemental Assay Method for in vitro Potency testing of Leptospira interrogans Serovar icterohaemorrhagiae Bacterins. 2009. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_sams_600_series.shtml.
    • (2009)
  • 108
    • 0030634560 scopus 로고    scopus 로고
    • Vitro methods for vaccine evaluation
    • Reitan LJ, Secombes CJ. In vitro methods for vaccine evaluation. Dev Biol Stand 1997; 90:293-301.
    • (1997) Dev Biol Stand. , vol.90 , pp. 293-301
    • Reitan, L.J.1    Secombes, C.J.2
  • 109
    • 0035452023 scopus 로고    scopus 로고
    • Aquaculture pharmaceuticals and biologicals: current perspectives and future possibilities
    • Shao Z. Aquaculture pharmaceuticals and biologicals: current perspectives and future possibilities. Advanced Drug Delivery Reviews 2001;50:229-243.
    • (2001) Advanced Drug Delivery Reviews. , vol.50 , pp. 229-243
    • Shao, Z.1
  • 110
    • 0030630917 scopus 로고    scopus 로고
    • Adjuvants and immunostimulants for enhancing vaccine potency in fish
    • Anderson DP. Adjuvants and immunostimulants for enhancing vaccine potency in fish. Salmon Bay Biologicals 1997;90:257-265.
    • (1997) Salmon Bay Biologicals. , vol.90 , pp. 257-265
    • Anderson, D.P.1
  • 111
    • 0022924278 scopus 로고
    • Reduction in animal usage for potency testing of diphtheria and tetanus toxoids
    • Stainer DW, Jakus CM, Sparkus JD. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids. Develop Biol Stand 1986;65:241-244.
    • (1986) Develop Biol Stand. , vol.65 , pp. 241-244
    • Stainer, D.W.1    Jakus, C.M.2    Sparkus, J.D.3
  • 112
    • 0022924283 scopus 로고
    • Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines
    • Knight PA, Roberts PAG. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines. Develop Biol Stand 1986;65:245-255.
    • (1986) Develop Biol Stand. , vol.65 , pp. 245-255
    • Knight, P.A.1    Roberts, P.A.G.2
  • 113
    • 64949139667 scopus 로고    scopus 로고
    • Potency evaluation of rabies vaccine for human use: the impact of the reduction in the number of animals per dilution
    • Correa de Moura W, Pinheiro de Araujo H, Cabello P. Potency evaluation of rabies vaccine for human use: the impact of the reduction in the number of animals per dilution. Journal of Virological Methods 2009;158:84-92.
    • (2009) Journal of Virological Methods , vol.158 , pp. 84-92
    • Correa de Moura, W.1    Pinheiro de Araujo, H.2    Cabello, P.3
  • 114
    • 84855915717 scopus 로고    scopus 로고
    • World Organization for Animal Health (2010). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 2.4.7. Pages 10-12.
    • World Organization for Animal Health (2010). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2010. Volume 2, Chapter 2.4.7. Pages 10-12. http://www.oie.int/eng/normes/mmanual/2008/pdf/2.04.07_BOVINE_TB.pdf.
    • (2010) , vol.1
  • 115
    • 0041549074 scopus 로고
    • NIH test, a problematic method for testing potency of inactivated rabies vaccine
    • Barth R, Diderrich G, Weinmann E. NIH test, a problematic method for testing potency of inactivated rabies vaccine. Vaccine 1988;6:369-377.
    • (1988) Vaccine. , vol.6 , pp. 369-377
    • Barth, R.1    Diderrich, G.2    Weinmann, E.3
  • 116
    • 0037567721 scopus 로고    scopus 로고
    • Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice
    • Wunderli PS, Dreesen DW, Miller TJ, Baer GM. Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice. Am J Vet Med 2003;64:491-498.
    • (2003) Am J Vet Med , vol.64 , pp. 491-498
    • Wunderli, P.S.1    Dreesen, D.W.2    Miller, T.J.3    Baer, G.M.4
  • 117
    • 84855915718 scopus 로고    scopus 로고
    • United States Department of Agriculture, Center for Veterinary Biologics, Veterinary Services Memorandum No. 800.112. Guidelines for validation of in vitro potency assays.
    • United States Department of Agriculture, Center for Veterinary Biologics, Veterinary Services Memorandum No. 800.112. Guidelines for validation of in vitro potency assays. 2008. http://www.aphis.usda.gov/animal_health/vet_biologics/vb_vs_memos_3.shtml.
    • (2008)
  • 118
    • 84855968475 scopus 로고    scopus 로고
    • International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Products (VICH): GL 41; TARGET ANIMAL SAFETY: EXAMINATION OF LIVE VETERINARY VACCINES IN TARGET ANIMALS FOR ABSENCE OF REVERSION TO VIRULENCE. Available at:
    • International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Products (VICH): GL 41; TARGET ANIMAL SAFETY: EXAMINATION OF LIVE VETERINARY VACCINES IN TARGET ANIMALS FOR ABSENCE OF REVERSION TO VIRULENCE. 2007. Available at: http://www.vichsec.org/en/guidelines2.htm.
    • (2007)
  • 119
    • 84855981852 scopus 로고    scopus 로고
    • International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Products (VICH): GL 44; Target Animal Safety for Veterinary Live and Inactivated vaccines. Available at:
    • International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Products (VICH): GL 44; Target Animal Safety for Veterinary Live and Inactivated vaccines. 2008. Available at: http://www.vichsec.org/en/guidelines2.htm.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.